Plutux
$18.64
+0.57%
2026-09-03 13:55:00 EDT+$0.11
Consumer Cyclical
Specialty Retail
NYSE
Active Trading

Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and ...

Price Action

$18.64
+0.57%+$0.11
High
Low
52W High-34.4%
Rel. vol
Interval
Range6.5h
VolumeSMA5SMA10
Bath & Body Works, Inc. (BBWI) is a global leader in personal care and home fragrance, headquartered in Columbus, Ohio. The company was founded in 1963 by Les Wexner and, after a series of transformations, became an independent public company in August 2021 when it separated from L Brands. Bath ...Bath & Body Works, Inc. (BBWI) is a global leader in personal care and home fragrance, headquartered in Columbus, Ohio. The company was founded in 1963 by Les Wexner and, after a series of transformations, became an independent public company in August 2021 when it separated from L Brands. Bath & Body Works operates through a network of retail stores and its e-commerce platform, primarily in the United States and Canada, and extends its reach internationally through franchise, license, and wholesale arrangements with partners across six continents. The company's product portfolio is diverse, encompassing body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, body creams, and sanitizers. These products are sold under the Bath & Body Works brand and other sub-brands, appealing to a broad consumer base seeking high-quality, aesthetically pleasing, and affordable fragrance and personal care items. Financially, Bath & Body Works has demonstrated resilience and profitability. As of the most recent trailing twelve months (TTM), the company reported a market capitalization of approximately $4.1 billion, with a gross profit margin of 43.2% and a net profit margin of 10%. The company's revenue per share stands at $35.87, and it has a price-to-earnings ratio of 5.87, indicating a potentially undervalued stock relative to earnings. Bath & Body Works also generates substantial free cash flow, with a free cash flow yield of 22.2%, and maintains a dividend yield of 3.9%, reflecting its commitment to returning value to shareholders. Key financial ratios paint a picture of operational efficiency: an inventory turnover of 5.26 times per year, a quick ratio of 0.81, and a current ratio of 1.38, suggesting adequate liquidity. The company has a debt-to-equity ratio of -4.16, which is negative due to negative shareholders' equity, a common situation for leveraged buyouts or large share repurchases. Despite this, the enterprise value to EBITDA ratio of 5.61 suggests a reasonable valuation relative to earnings before interest, taxes, depreciation, and amortization. Under the leadership of CEO Daniel Heaf, who was appointed in May 2025, the company continues to innovate and expand its product offerings. The leadership team is focused on strategic growth, enhancing the customer experience, and maintaining Bath & Body Works' reputation as a beloved brand. The company is also committed to social responsibility, including sustainability initiatives and community engagement, as highlighted in its 'Impacts Through Fragrance' program. With 60,700 employees, Bath & Body Works is a major employer and a significant player in the specialty retail sector. Its strong brand loyalty, extensive distribution network, and consistent financial performance position it well for future growth in the competitive personal care and home fragrance market.
Founded
1963
Employees
60735
CEO
Daniel Heaf
Full Name
Bath & Body Works, Inc.
Sector
Consumer Cyclical
Industry
Specialty Retail
ROE
-61.76%
Market Cap
$3.76B
Current Ratio
1.20
WACC
7.44%
ROIC
30.35%

Contact Information

614 415 7000
Three Limited Parkway, Columbus, OH 43230

Related stocksSpecialty Retail

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026